Hyderabad Telangana, India

Brajesh Kumar Sinha


 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Brajesh Kumar Sinha: Innovator in Pharmaceutical Chemistry

Introduction

Brajesh Kumar Sinha is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of proton pump inhibitors. His work is characterized by a focus on improving processes for drug preparation, which is crucial for the pharmaceutical industry.

Latest Patents

Brajesh Kumar Sinha holds a patent for a process titled "Process for preparing an optically active proton pump inhibitor." This patent describes an improved method for the preparation of (S)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole with high enantiomeric excess from a racemic mixture. This innovation is significant as it enhances the efficiency and effectiveness of proton pump inhibitors, which are widely used in treating various gastrointestinal disorders.

Career Highlights

Sinha is currently employed at Aurobindo Pharma Limited, a prominent player in the pharmaceutical sector. His role involves research and development, where he applies his expertise to create innovative solutions that meet the needs of the market. His contributions have not only advanced the company's portfolio but have also positively impacted patient care.

Collaborations

Throughout his career, Brajesh Kumar Sinha has collaborated with several talented professionals, including Shankar Reddy Budidet and Somappa Somannavar Yallappa. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking pharmaceutical solutions.

Conclusion

Brajesh Kumar Sinha is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in drug preparation processes. His patent for an optically active proton pump inhibitor exemplifies his commitment to innovation in the field. His contributions continue to shape the future of pharmaceuticals, benefiting both the industry and patients alike.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…